Phreesia ROA 2019-2025 | PHR

Current and historical return on assets (ROA) values for Phreesia (PHR) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Phreesia ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2025-01-31 $-0.06B $0.39B -15.49%
2024-10-31 $-0.08B $0.38B -22.43%
2024-07-31 $-0.10B $0.36B -27.32%
2024-04-30 $-0.12B $0.37B -32.94%
2024-01-31 $-0.14B $0.37B -38.36%
2023-10-31 $-0.15B $0.38B -40.31%
2023-07-31 $-0.15B $0.34B -41.89%
2023-04-30 $-0.16B $0.35B -42.15%
2023-01-31 $-0.18B $0.37B -42.62%
2022-10-31 $-0.18B $0.40B -41.44%
2022-07-31 $-0.18B $0.43B -37.74%
2022-04-30 $-0.16B $0.46B -30.89%
2022-01-31 $-0.12B $0.49B -21.92%
2021-10-31 $-0.08B $0.53B -16.06%
2021-07-31 $-0.05B $0.55B -11.25%
2021-04-30 $-0.03B $0.56B -9.24%
2021-01-31 $-0.03B $0.33B -10.95%
2020-10-31 $-0.02B $0.34B -11.25%
2020-07-31 $-0.02B $0.16B -11.32%
2020-04-30 $-0.08B $0.16B -51.96%
2020-01-31 $-0.09B $0.16B -76.99%
2019-07-31 $-0.10B $0.16B -242.94%
2019-04-30 $-0.04B $0.00B 0.00%
Sector Industry Market Cap Revenue
Medical Medical Information Systems $1.510B $0.420B
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $39.499B 54.56
Hims & Hers Health (HIMS) United States $14.471B 150.35
Tempus AI (TEM) United States $11.278B 0.00
Inspire Medical Systems (INSP) United States $4.503B 70.35
IRhythm Technologies (IRTC) United States $4.501B 0.00
Privia Health (PRVA) United States $3.050B 208.50
Enovis (ENOV) United States $2.060B 11.48
Clover Health Investments (CLOV) United States $1.807B 0.00
Schrodinger (SDGR) United States $1.722B 0.00
Omnicell (OMCL) United States $1.310B 23.11
Azenta (AZTA) United States $1.258B 58.45
10x Genomics (TXG) United States $1.148B 0.00
Fulgent Genetics (FLGT) United States $0.620B 0.00
Butterfly Network (BFLY) United States $0.581B 0.00
Talkspace (TALK) United States $0.499B 149.00
Veradigm (MDRX) United States $0.455B 0.00
Claritev (CTEV) United States $0.450B 0.00
Standard BioTools (LAB) United States $0.410B 0.00
TruBridge (TBRG) United States $0.376B 834.67
Health Catalyst (HCAT) United States $0.283B 0.00
Nyxoah SA (NYXH) Belgium $0.214B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.197B 0.00
EUDA Health Holdings (EUDA) Singapore $0.142B 0.00
Pulmonx (LUNG) United States $0.138B 0.00
American Well (AMWL) United States $0.116B 0.00
MDxHealth SA (MDXH) Belgium $0.099B 0.00
CareCloud (CCLD) United States $0.089B 3.39
Outset Medical (OM) United States $0.070B 0.00
111 (YI) China $0.067B 0.00
Retrieve Medical Holdings (RMHI) United States $0.059B 0.00
P3 Health Partners (PIII) United States $0.057B 0.00
HeartBeam (BEAT) United States $0.052B 0.00
Zepp Health (ZEPP) Netherlands $0.042B 0.00
Zhongchao (ZCMD) China $0.032B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.023B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
MSP Recovery (MSPR) United States $0.013B 0.00
Precipio (PRPO) United States $0.012B 0.00
Strata Skin Sciences (SSKN) United States $0.011B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00